探索抗疟疾潜力:将有机金属部分与有机碎片结合起来,以提高疗效
Nur Aqilah Zahirah Norazmi1, Nur Hafizah Mukhtar1, Lekkala Ravindar1
1Department of Chemical Sciences, Faculty of Science & Technology, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia.
Bioorganic chemistry
|June 4, 2024
概括
有机金属化合物,如铁,显示出治疗寄生虫疾病,特别是疟疾的前景. 本综述强调了过去十年有机金属抗疟疾药物的进展,重点关注各种分子设计.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 寄生虫学的寄生虫学
背景情况:
- 将有机金属单元分子杂交成生物活性支架是药物化学中开发新型治疗剂的关键策略.
- 氨酸 (FQ) 是一种氨酸-铁联体,在疟疾治疗中的成功显著增加了对有机金属化合物药物发现的兴趣.
- 有机金属化合物具有独特的特性,可用于开发针对各种疾病,特别是寄生虫感染的新药.
研究的目的:
- 审查过去十年开发的有机金属抗疟疾药物的演变.
- 根据它们的原始部分和使用的有机金属碎片类型来分类这些药物.
- 讨论不同有机支架与有机金属结合用于抗疟疾药物开发的潜力.
主要方法:
- 在过去10年发表的关于有机金属抗疟疾化合物的文献综述.
- 基于结合有机部分的化合物的分类:现有的抗疟药物,其他临床药物,混合药物和新型支架 (thiosemicarbazones,benzimidazoles, chalcones).
- 对所选有机金属化合物结构特征和抗疟疾功效的分析.
主要成果:
- 该审查涵盖了有机金属抗疟疾药物的进展,包括现有药物的结合物和新型混合结构.
- 根据它们的有机成分确定了四种主要类型的有机金属抗疟药化合物:现有的抗疟药物,其他临床药物,混合药物和有前途的支架.
- 特定的支架,如与有机金属单元相结合的西米卡巴,西米达和,显示出显著的潜力.
结论:
- 有机金属抗疟疾药物开发取得了实质性的进展,主要是由于成功的例子,如费洛奎因.
- 混合化策略通过将金属中心与多种有机框架相结合,为设计强大的抗疟疾药物提供了一种多功能方法.
- 对有机金属化合物的持续研究有望解决疟疾和其他寄生虫疾病的挑战.
相关概念视频
01:23Properties of Organometallic Compounds
990
Organometallic compounds are compounds that contain a carbon–metal bond. Carbon belongs to an organyl group like alkyl, aryl, allyl, or benzyl groups. The metal can be from Group I or Group II of the periodic table, a transition metal, or a semimetal.
990
00:56Extraction: Advanced Methods
446
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
446
01:14Phase II Conjugation Reactions: Overview
187
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
187
02:51Metal-Ligand Bonds
20.7K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
20.7K
01:19Complexation Equilibria: The Chelate Effect
501
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
501
01:19Phase II Reactions: Miscellaneous Conjugation Reactions
58
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
58